Macular Degeneration, Age-Related, 14

Watchlist
Retrieved
2019-09-22
Source
Trials
—
Genes
CFB, C2
Drugs
—

A number sign (#) is used with this entry because of evidence that variation at or near the C2 (613927) and CFB (138470) genes on chromosome 6p21 influences susceptibility to age-related macular degeneration.

For a phenotypic description and a discussion of genetic heterogeneity of age-related macular degeneration (ARMD), see 603075.

Molecular Genetics

Because CFH (134370) haplotypes are associated with age-related macular degeneration (ARMD4; 610698), Gold et al. (2006) hypothesized that the same may be true for activators of the same pathway. Gold et al. (2006) screened the CFB (138470) and C2 (613927) genes for genetic variation in 2 independent cohorts comprising approximately 900 individuals with ARMD and approximately 400 matched controls. Haplotype analyses identified a statistically significant common risk haplotype and 2 protective haplotypes. Haplotype H10, consisting of the L9H variant (138470.0003) of CFB and the E318D variant (613927.0004) of C2, and haplotype H7, consisting of the variant in intron 10 (613927.0005) of C2 and the R32Q variant (138470.0004) of CFB, conferred a significantly reduced risk of ARMD (OR = 0.36 and 0.45, respectively). Combined analysis of the C2/CFB haplotypes and CFH variants showed that variation in the 2 loci can predict the clinical outcome in 74% of affected individuals and 56% of controls.

Fritsche et al. (2013) executed a collaborative genomewide association study, including more than 17,100 advanced ARMD cases and more than 60,000 controls of European and Asian ancestry. They identified 19 loci associated at p less than 5 x 10(-8). These loci showed enrichment for genes involved in the regulation of complement activity, lipid metabolism, extracellular matrix remodeling, and angiogenesis. Fritsche et al. (2013) identified association of the G allele of rs429608, near the C2 and CFB genes on chromosome 6p21.3, with increased risk of age-related macular degeneration (OR 1.74, 95% CI 1.68-1.79, combined p = 4 x 10(-89)).